Video

Episode 24 - Accountable Care Organizations

During this segment, David Calabrese, RPh, MHP, and Kenneth L. Schaecher, MD, FACP, CPC, discuss accountable care organizations (ACOs) and their impact on patient care.

Dr Schaecher explains that although ACOs are constructed to benefit healthcare professionals and patients, he fears that an ACO model of care may cause clinicians to under-utilize expensive drug

therapies.

Dr Schaecher hopes that healthcare professionals will continue to make the best choice for their patients and ignore the financial pressures that often play a role in the treatment decision-making process.


Related Videos
Mike Fazio, Navista, Cardinal Health
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Dr Kimlin Tam Ashing
Jaime Almandoz, MD, MBA
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Leigh Maria Ramos-Platt, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo